Germline Genetic Testing in Breast Cancer: Systemic Therapy Implications

被引:0
|
作者
Prarthna V. Bhardwaj
Yara G. Abdou
机构
[1] University of Massachusetts Chan School of Medicine – Baystate,Division of Hematology
[2] University of North Carolina at Chapel Hill,Oncology
来源
Current Oncology Reports | 2022年 / 24卷
关键词
Breast cancer; Germline genetic testing; BRCA1; BRCA2; PARP inhibitors; Systemic therapy; Targeted therapies; Olaparib;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1791 / 1800
页数:9
相关论文
共 50 条
  • [1] Germline Genetic Testing in Breast Cancer: Systemic Therapy Implications
    Bhardwaj, Prarthna, V
    Abdou, Yara G.
    CURRENT ONCOLOGY REPORTS, 2022, 24 (12) : 1791 - 1800
  • [2] Somatic Testing and Germline Genetic Status: Implications for Cancer Treatment Decisions and Genetic Counseling
    Swan, Kelli
    Dougherty, Kali Chatham
    Myers, Sara Wienke
    CURRENT GENETIC MEDICINE REPORTS, 2020, 8 (03) : 109 - 119
  • [3] Implications of BRCA Germline Mutations on Breast Cancer Medical Treatment
    Le Du, Fanny
    Brunot, Angelique
    Rouge, Thibault de la Motte
    Dieras, Veronique
    CURRENT BREAST CANCER REPORTS, 2020, 12 (02) : 59 - 65
  • [4] Clinical Utility of Universal Germline Genetic Testing for Patients With Breast Cancer
    Whitworth, Pat W.
    Beitsch, Peter D.
    Patel, Rakesh
    Rosen, Barry
    Compagnoni, Gia
    Baron, Paul L.
    Simmons, Rache
    Brown, Eric A.
    Gold, Linsey
    Holmes, Dennis
    Smith, Linda Ann
    Kinney, Michael
    Grady, Ian
    Clark, Patricia
    Barbosa, Karen
    Lyons, Samuel
    Riley, Lee
    Coomer, Cynara
    Curcio, Lisa
    Ruiz, Antonio
    Khan, Sadia
    MacDonald, Heather
    Hughes, Kevin
    Hardwick, Mary Kay
    Heald, Brandie
    Munro, Sandra B.
    Nielsen, Sarah M.
    Esplin, Edward D.
    JAMA NETWORK OPEN, 2022, 5 (09) : E2232787
  • [5] Ethical implications of genetic testing for breast cancer susceptibility
    Surbone, A
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2001, 40 (02) : 149 - 157
  • [6] Genetic testing in women with breast cancer: implications for treatment
    Paterson, Robin
    Phillips, Kelly-Anne
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (11) : 991 - 1002
  • [7] Access disparities and underutilization of germline genetic testing in Chilean breast cancer patients
    Francisco Acevedo
    Benjamín Walbaum
    Mauricio Camus
    Manuel Manzor
    Sabrina Muñiz
    Lidia Medina
    Militza Petric
    Paula Reyes
    Francisco Domínguez
    Klaus Puschel
    Tomas Merino
    M. Loreto Bravo
    Mauricio P. Pinto
    Carolina Ibáñez
    Kevin Hughes
    César Sánchez
    Breast Cancer Research and Treatment, 2023, 199 : 363 - 370
  • [8] Access disparities and underutilization of germline genetic testing in Chilean breast cancer patients
    Acevedo, Francisco
    Walbaum, Benjamin
    Camus, Mauricio
    Manzor, Manuel
    Muniz, Sabrina
    Medina, Lidia
    Petric, Militza
    Reyes, Paula
    Dominguez, Francisco
    Puschel, Klaus
    Merino, Tomas
    Bravo, M. Loreto
    Pinto, Mauricio P.
    Ibanez, Carolina
    Hughes, Kevin
    Sanchez, Cesar
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 199 (02) : 363 - 370
  • [9] Primary systemic therapy in breast cancer
    Goehring, Uwe-Jochen
    Solomayer, Erich
    BREAST CARE, 2006, 1 (04) : 234 - 237
  • [10] Systemic therapy of male breast cancer
    Eucker, J.
    Kuehn, A.
    Possinger, K.
    ZENTRALBLATT FUR CHIRURGIE, 2007, 132 (05): : 396 - 399